Cancer Biology & Medicine: 21 (7)

July 15, 2024; Volume 21,Issue 7

An, Liwei
1. Open Access
  Modeling human gastric cancers in immunocompetent mice
  Weihong Zhang, Shilong Wang, Hui Zhang, Yan Meng, Shi Jiao, Liwei An and Zhaocai Zhou
  
  Cancer Biology & Medicine July 2024, 21 (7) 553-570; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0124
Ba, Yi
1. Open Access
  Phase Ib study of anti-EGFR antibody (SCT200) in combination with anti-PD-1 antibody (SCT-I10A) for patients with RAS/BRAF wild-type metastatic colorectal cancer
  Ming Bai, Yao Lu, Chunmei Shi, Jianwei Yang, Wei Li, Xianli Yin, Chenghui Huang, Lin Shen, Liangzhi Xie and Yi Ba
  
  Cancer Biology & Medicine July 2024, 21 (7) 636-650; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0301
Bai, Ming
1. Open Access
  Phase Ib study of anti-EGFR antibody (SCT200) in combination with anti-PD-1 antibody (SCT-I10A) for patients with RAS/BRAF wild-type metastatic colorectal cancer
  Ming Bai, Yao Lu, Chunmei Shi, Jianwei Yang, Wei Li, Xianli Yin, Chenghui Huang, Lin Shen, Liangzhi Xie and Yi Ba
  
  Cancer Biology & Medicine July 2024, 21 (7) 636-650; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0301
Cao, Liu
1. Open Access
  Unraveling the nexus between cellular senescence and malignant transformation: a paradigm shift in cancer research
  Xiaoyu Song, Xiyan Liu, Qiqiang Guo, Hongde Xu and Liu Cao
  
  Cancer Biology & Medicine July 2024, 21 (7) 541-546; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0157
Dong, Haoran
1. Open Access
  ACSL3 regulates breast cancer progression via lipid metabolism reprogramming and the YES1/YAP axis
  Shirong Tan, Xiangyu Sun, Haoran Dong, Mozhi Wang, Litong Yao, Mengshen Wang, Ling Xu and Yingying Xu
  
  Cancer Biology & Medicine July 2024, 21 (7) 606-635; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0309
Fu, Yubin
1. Open Access
  Progress on immuno-microenvironment and immune-related therapies in patients with pseudomyxoma peritonei
  Qidi Zhao, Tian Wei, Ru Ma, Yubin Fu, Rui Yang, Yandong Su, Yang Yu, Bing Li and Yan Li
  
  Cancer Biology & Medicine July 2024, 21 (7) 586-605; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0109
Guo, Qiqiang
1. Open Access
  Unraveling the nexus between cellular senescence and malignant transformation: a paradigm shift in cancer research
  Xiaoyu Song, Xiyan Liu, Qiqiang Guo, Hongde Xu and Liu Cao
  
  Cancer Biology & Medicine July 2024, 21 (7) 541-546; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0157
Huang, Chenghui
1. Open Access
  Phase Ib study of anti-EGFR antibody (SCT200) in combination with anti-PD-1 antibody (SCT-I10A) for patients with RAS/BRAF wild-type metastatic colorectal cancer
  Ming Bai, Yao Lu, Chunmei Shi, Jianwei Yang, Wei Li, Xianli Yin, Chenghui Huang, Lin Shen, Liangzhi Xie and Yi Ba
  
  Cancer Biology & Medicine July 2024, 21 (7) 636-650; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0301
Jiao, Shi
1. Open Access
  Modeling human gastric cancers in immunocompetent mice
  Weihong Zhang, Shilong Wang, Hui Zhang, Yan Meng, Shi Jiao, Liwei An and Zhaocai Zhou
  
  Cancer Biology & Medicine July 2024, 21 (7) 553-570; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0124
Li, Bing
1. Open Access
  Progress on immuno-microenvironment and immune-related therapies in patients with pseudomyxoma peritonei
  Qidi Zhao, Tian Wei, Ru Ma, Yubin Fu, Rui Yang, Yandong Su, Yang Yu, Bing Li and Yan Li
  
  Cancer Biology & Medicine July 2024, 21 (7) 586-605; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0109

Main menu

User menu

Search

Table of Contents

An, Liwei

Ba, Yi

Bai, Ming

Cao, Liu

Dong, Haoran

Fu, Yubin

Guo, Qiqiang

Huang, Chenghui

Jiao, Shi

Li, Bing

In this issue

Navigate

More Information

For Authors

Journal Services